Activation of spleen tyrosine kinase is required for TNF-α-induced endothelin-1 upregulation in human aortic endothelial cells
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Activation of spleen tyrosine kinase is required for TNF-α-induced endothelin-1 upregulation in human aortic endothelial cells
Authors
Keywords
-
Journal
FEBS LETTERS
Volume 586, Issue 6, Pages 818-826
Publisher
Wiley
Online
2012-02-03
DOI
10.1016/j.febslet.2012.01.055
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cryptotanshinone enhances TNF-α-induced apoptosis in chronic myeloid leukemia KBM-5 cells
- (2011) Ji-Hyun Kim et al. APOPTOSIS
- The Oral Spleen Tyrosine Kinase Inhibitor Fostamatinib Attenuates Inflammation and Atherogenesis in Low-Density Lipoprotein Receptor–Deficient Mice
- (2011) Ingo Hilgendorf et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Darbepoetin alfa suppresses tumor necrosis factor-α-induced endothelin-1 production through antioxidant action in human aortic endothelial cells: Role of sialic acid residues
- (2011) Won Seok Yang et al. FREE RADICAL BIOLOGY AND MEDICINE
- Mycophenolic acid attenuates tumor necrosis factor-α-induced endothelin-1 production in human aortic endothelial cells
- (2010) Won Seok Yang et al. ATHEROSCLEROSIS
- Age-associated changes in the subcellular localization of phosphorylated p38 MAPK in human granulosa cells
- (2010) M. Ito et al. MOLECULAR HUMAN REPRODUCTION
- Endothelin-1 activates ETA receptors on human vascular smooth muscle cells to yield proteoglycans with increased binding to LDL
- (2009) Mandy L. Ballinger et al. ATHEROSCLEROSIS
- Vascular endothelial cell-derived endothelin-1 mediates vascular inflammation and neointima formation following blood flow cessation
- (2009) Dyah W. Anggrahini et al. CARDIOVASCULAR RESEARCH
- Lipoprotein Accumulation in Macrophages via Toll-Like Receptor-4–Dependent Fluid Phase Uptake
- (2009) Soo-Ho Choi et al. CIRCULATION RESEARCH
- Activator Protein-1 Has an Essential Role in Pancreatic Cancer Cells and Is Regulated by a Novel Akt-Mediated Mechanism
- (2009) S. Shin et al. MOLECULAR CANCER RESEARCH
- Treatment of rheumatoid arthritis with a syk kinase inhibitor: A twelve-week, randomized, placebo-controlled trial
- (2008) Michael E. Weinblatt et al. ARTHRITIS AND RHEUMATISM
- An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus
- (2008) Frances Rena Bahjat et al. ARTHRITIS AND RHEUMATISM
- Endothelin-1 signalling in vascular smooth muscle: Pathways controlling cellular functions associated with atherosclerosis
- (2008) Melanie E. Ivey et al. ATHEROSCLEROSIS
- Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk
- (2008) A. Podolanczuk et al. BLOOD
- Endothelin-1 Actions on Vascular Smooth Muscle Cell Functions As a Target for the Prevention of Atherosclerosis
- (2008) Peter Little et al. Current Vascular Pharmacology
- Invited review: Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms
- (2008) Harald Loppnow et al. Innate Immunity
- Syk inhibitors as treatment for allergic rhinitis
- (2007) Esteban S. Masuda et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation